# Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty

> **NCT01038297** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 30 (actual)

## Conditions studied

- Scar Prevention

## Interventions

- **DRUG:** EXC 001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01038297
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12-01
- **Primary completion:** 2010-07-07
- **Final completion:** 2010-07-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01038297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01038297, "Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01038297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*